RGEN News and Press, Repligen Corporation From 03/28/21

What do a leading fintech player, a mobile communications company, and a key supplier to the bioprocessing industry all have in common? The businesses in question are PayPal (NASDAQ: PYPL) , Digital Turbine (NASDAQ: APPS) , and Repligen (NASDAQ: RGEN) , and t...

As Q1 earnings season approaches, the consensus is for 28% bottom-line growth, which would be the best showing since Q3 2018.In the last quarter, "the immediate market reactions were mixed for positive surprises, while negative surprises were punished," Citi analysts write in a note.For Q1, t...

WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 23-24.  ...

WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the Barclays Global Healthcare Conference being held March 9-11. Jon Snodgres, Chi...

Image source: The Motley Fool. Repligen Corp (NASDAQ: RGEN) Q4 2020 Earnings Call Feb 24, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript

Repligen Corporation (RGEN) Q4 2020 Earnings Conference Call February 24, 2021 08:30 A.M. ET Company Participants Sondra Newman - Global Head of IR Tony J. Hunt - President and CEO Jon K. Snodgres - CFO Conference Call Participants Dan Arias - Stifel Unidentified Analyst - J.P. Morgan Paul Kn...

Repligen (RGEN): Q4 Non-GAAP EPS of $0.52 beats by $0.21; GAAP EPS of $0.36 beats by $0.19.Revenue of $108.64M (+56.4% Y/Y) beats by $14.7M.FISCAL YEAR 2021 GUIDANCE:  Total revenue is expected to be in the range of $500-$525 million ($459.5M consensus), reflecting overall revenue growth...

Reports quarterly revenue of $108.6 million, representing 56% year-over-year growth, and annual revenue of $366.3 million represents 36% year-over-year growth Organic revenue growth was 47% for the fourth quarter and 29% for the year 2020 WALTHAM, Mass., Feb. 24, 2021 ...

[[AVA]], [[BHC]], [[CLH]], [[CQP]], [[CSPR]], [[DEA]], [[ELAN]], [[ENBL]], [[ETR]], [[EV]], [[EXC]], [[FDP]], [[GCP]], [[HFC]], [[HZNP]], [[IBP]], [[IONS]], [[IRM]], [[ITRI]], [[KOP]], [[LIVN]], [[LNG]], [[LOW]], [[NEO]], [[ODP]], [[OMI]], [[OSTK]], [[PGTI]], [[PLAB]], [[PNW]], [[PSN]], [[RGE...

WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 10th Annual SVB Leerink Healthcare conference being held February 22-26.&#...